| 000 | 01786 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513124013.0 | ||
| 264 | 0 | _c19970919 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0008-8749 | ||
| 024 | 7 |
_a10.1006/cimm.1997.1162 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLamousé-Smith, E | |
| 245 | 0 | 0 |
_aAllospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype. _h[electronic resource] |
| 260 |
_bCellular immunology _cAug 1997 |
||
| 300 |
_a107-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Blocking _xpharmacology |
| 650 | 0 | 4 |
_aCD4 Antigens _ximmunology |
| 650 | 0 | 4 |
_aCD8 Antigens _ximmunology |
| 650 | 0 | 4 |
_aCell-Free System _ximmunology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aConcanavalin A _xpharmacology |
| 650 | 0 | 4 |
_aCytokines _xpharmacology |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 |
_aEpitopes _ximmunology |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _ximmunology |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 |
_aIsoantigens _ximmunology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aLymphocyte Culture Test, Mixed |
| 650 | 0 | 4 | _aLymphocyte Transfusion |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aSpleen _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _xclassification |
| 650 | 0 | 4 |
_abeta 2-Microglobulin _ximmunology |
| 700 | 1 | _aMcCarthy, S A | |
| 773 | 0 |
_tCellular immunology _gvol. 179 _gno. 2 _gp. 107-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/cimm.1997.1162 _zAvailable from publisher's website |
| 999 |
_c9248042 _d9248042 |
||